Search alternatives:
decrease » increase (Expand Search)
sars » sara (Expand Search)
Showing 1 - 20 results of 59 for search '(( significant ((bias decrease) OR (point decrease)) ) OR ( significant different sars ))', query time: 0.11s Refine Results
  1. 1

    Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants by Hebah A., Al-Khatib

    Published 2022
    “…Here, we evaluated the within-host diversity among vaccinated and unvaccinated individuals (n = 379) infected with different SARS-CoV-2 Variants of Concern. The majority of samples harbored less than 14 intra-host single-nucleotide variants (iSNVs). …”
    Get full text
    Get full text
    Get full text
    article
  2. 2

    Tranexamic Acid for Traumatic Injury in the Emergency Setting: A Systematic Review and Bias-Adjusted Meta-Analysis of Randomized Controlled Trials by Pieter Francsois, Fouche

    Published 2024
    “…Study objectiveTraumatic injury causes a significant number of deaths due to bleeding. Tranexamic acid (TXA), an antifibrinolytic agent, can reduce bleeding in traumatic injuries and potentially enhance outcomes. …”
    Get full text
    Get full text
    Get full text
    article
  3. 3
  4. 4

    Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above by Mohamed Ahmed Syed (8794121)

    Published 2022
    “…The overall point prevalence and period prevalence were estimated to be 1.6% (95% CI 1.1–2.2) and 14.6% (95% CI 13.1–16.2) respectively. Period prevalence of SARS-CoV2 infection was not considerably different across age groups (9.7–19.8%). …”
  5. 5

    Host Genetic Variants Potentially Associated With SARS-CoV-2: A Multi-Population Analysis by Maria K. Smatti (4675852)

    Published 2020
    “…<h3>Background</h3><p dir="ltr">Clinical outcomes of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) showed enormous inter-individual and inter-population differences, possibly due to host genetics differences. …”
  6. 6

    SARS‐CoV‐2 omicron variant may present with severe sickle cell painful crisis: A report of two cases by Elrazi Ali (14777284)

    Published 2023
    “…Currently, the virus had shown significant changes and mutations that resulted in the emergence of different strains. …”
  7. 7

    Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection by Haissam Abou-Saleh (497840)

    Published 2022
    “…In the NI group, a significant but less steady decline was notable in S-RBD-IgM (~2-fold, <i>P</i> < 0.001), and a much smaller but significant difference in NTAb (<2-fold, <i>P</i> < 0.001) anti-S-RBD IgG (<2-fold, <i>P</i> = 0.005). …”
  8. 8

    Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort by Muneerah Smith (12542939)

    Published 2021
    “…Additionally, we observed significant differences in the breadth and strength of the humoral immune response in relation to ethnicity, which may reflect differences in genetic and lifestyle factors. …”
  9. 9
  10. 10

    Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study by Farah M. Shurrab (16324961)

    Published 2022
    “…However, the difference between the immune response in naïve mRNA-vaccinated and previously infected (PI) individuals is not well studied. …”
  11. 11

    SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines by Hadeel T. Zedan (12535521)

    Published 2024
    “…Also, there was no difference in ADCC levels across the four vaccines, although NAbs and binding antibody titers were significantly higher in mRNA‐vaccinated individuals. …”
  12. 12
  13. 13
  14. 14
  15. 15

    Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients by Sara Al-Khawaga (4792761)

    Published 2020
    “…Mesenchymal stem cells (MSCs) have been proposed as an emerging therapeutic option for the SARS-CoV-2 infection. Recently, numerous clinical trials have been registered to examine the safety and efficacy of different types of MSCs and their exosomes for treating COVID-19 patients, with less published data on the mechanism of action. …”
  16. 16
  17. 17

    Nonlinear Control of Brushless Dual-Fed Induction Generator With a Flywheel Energy Storage System for Improved System Performance by Mohammed Hamidat (3722086)

    Published 2025
    “…After optimization, the SMC settling time was significantly reduced from 0.7 seconds to 19.97 milliseconds, achieving a 96.9% improvement in response speed, while its steady-state error decreased from 0.48 to 0.06, marking an 87.5% reduction in tracking error. …”
  18. 18
  19. 19

    Efficacy and safety of the newer oral hypoglycemic agents in patients with T2DM during Ramadan: A systematic review and meta-analysis by Hoda Gad (6470522)

    Published 2020
    “…Glucagon-like peptide (GLP-1) agonist therapy was associated with a significant decrease in Hb<sub>A1c</sub> (%) (SMD -0.68) and a non-significant decrease in weight (kg) (SMD -2.57) and systolic blood pressure (SBP) (mmHg) (SMD -3.50) after Ramadan. …”
  20. 20

    The effect of Ramadan focused education on patients with type 2 diabetes: A systematic review and meta-analysis by Hoda Gad (6470522)

    Published 2020
    “…Quality assessment was done using the ROBINS-I and Cochrane tools for risk of bias and analyses were performed using RevMan version 5.1.…”